XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Accumulated Deficit
Balance, beginning of period at Jan. 30, 2021 $ 94,922 $ 174,391 $ (79,469)
Balance, beginning of period (in shares) at Jan. 30, 2021   14,292,250  
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Exercise of stock options 177 $ 177  
Exercise of stock options (in shares)   49,454  
Restricted stock issued   120,468  
Net share settlement of stock options and restricted stock units (379) $ (379)  
Net share settlement of stock options and restricted stock units (in shares)   (21,504)  
Stock-based compensation expense 1,667 $ 1,667  
Repurchase and retirement of common stock $ (37,287)   (37,287)
Repurchase and retirement of common stock (in shares) (1,809,321) (1,809,321)  
Net (loss) income $ 22,026   22,026
Balance, end of period at Jan. 29, 2022 81,126 $ 175,856 (94,730)
Balance, end of period (in shares) at Jan. 29, 2022   12,631,347  
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Exercise of stock options 16 $ 16  
Exercise of stock options (in shares)   2,705  
Restricted stock issued   826,423  
Net share settlement of stock options and restricted stock units (2,383) $ (2,383)  
Net share settlement of stock options and restricted stock units (in shares)   (226,141)  
Stock-based compensation expense 1,961 $ 1,961  
Repurchase and retirement of common stock $ (6,253)   (6,253)
Repurchase and retirement of common stock (in shares) (479,966) (479,966)  
Net (loss) income $ (44,694)   (44,694)
Balance, end of period at Jan. 28, 2023 $ 29,773 $ 175,450 (145,677)
Balance, end of period (in shares) at Jan. 28, 2023 12,754,368 12,754,368  
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Exercise of stock options $ 0    
Restricted stock issued   202,967  
Net share settlement of restricted stock units (84) $ (84)  
Net share settlement of restricted stock units (in shares)   (31,313)  
Stock-based compensation expense $ 1,186 $ 1,186  
Repurchase and retirement of common stock (in shares) 0    
Net (loss) income $ (27,751)   (27,751)
Balance, end of period at Feb. 03, 2024 $ 3,124 $ 176,552 $ (173,428)
Balance, end of period (in shares) at Feb. 03, 2024 12,926,022 12,926,022